Prenatal Smoking Cessation Medication Did Not Increase Congenital Malformations

Quit-smoking aids do not increase risk: study

New research shows the use of nicotine replacement therapy and varenicline, to help pregnant women quit smoking, do not increase the risk of major birth defects. PHOTO: GETTY IMAGES It is well known that smoking during pregnancy can increase the chance of certain birth defects in babies.

Prenatal Smoking Cessation Medication Did Not Increase Congenital Malformations

(MedPage Today) -- Prenatal use of smoking cessation therapies was not linked to increased risks of major congenital malformations (MCMs) compared with smoking during the first trimester, a retrospective cohort study suggested. Compared with unexposed...

Smoking Cessation Drugs Don’t Promote Congenital Malformations

Large retrospective study supports benefits of quitting with smoking cessation medications over risks of smoking. Medscape Medical News

Pregnant women warned some vapes could cause birth defects

Scientists say it would be sensible to avoid all vapes until more research has been done

No evidence quit smoking medicines increase risk of major birth defects: study

A large-scale study has revealed encouraging findings for pregnant women who use quit-smoking medicines.

No evidence quit smoking treatments increase risk of major birth defec

Pregnant women can be reassured that quit smoking treatments such as nicotine patches and varenicline, sold in Australia as Champix, do not increase the risk of major birth defects in babies, according to new research led by the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney. The real-world data suggest there is no evidence that infants exposed to these medicines had higher rates of major congenital malformations.